Afana Biotechnology Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 13

Afana Biotechnology General Information

Description

Developer of programmable rna medicines designed to develop therapies for patients with unmet medical needs. The company's technology integrates rna engineering, precision delivery and immune programming, enabling the healthcare sector to access autoimmune disease therapies, cancer vaccines, prophylactic vaccines, respiratory syncytial virus vaccines, herpes zoster vaccines and solid tumor immunotherapies.

Contact Information

Website
www.rnalfa.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4th Floor, Building 2, Phase II, Intelligent Technology Park
  • Number 3963 Susong Road
  • Hefei, Anhui 230011
  • China
+86 155
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4th Floor, Building 2, Phase II, Intelligent Technology Park
  • Number 3963 Susong Road
  • Hefei, Anhui 230011
  • China
+86 155

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Afana Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 06-Nov-2026 Completed Generating Revenue
7. Secondary Transaction - Private 06-Jun-2025 Completed Generating Revenue
6. Early Stage VC (Series A) 11-Mar-2025 Completed Generating Revenue
5. Early Stage VC 22-Apr-2024 Completed Generating Revenue
4. Early Stage VC 28-Nov-2023 Completed Generating Revenue
3. Early Stage VC 24-Feb-2023 Completed Generating Revenue
2. Early Stage VC 25-Nov-2022 Completed Generating Revenue
1. Early Stage VC 19-Aug-2022 Completed Generating Revenue
To view Afana Biotechnology’s complete valuation and funding history, request access »

Afana Biotechnology Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shenzhen Guozhong Venture Capital Management Venture Capital Minority
Anhui Lianyuan Venture Capital Venture Capital Minority
Hefei Innovation Technology Venture Capital Growth/Expansion Minority
USTC Silicon Valley University Minority
Anhui Capital Asset Manager Minority
You’re viewing 5 of 13 investors. Get the full list »

Afana Biotechnology FAQs

  • When was Afana Biotechnology founded?

    Afana Biotechnology was founded in 2021.

  • Where is Afana Biotechnology headquartered?

    Afana Biotechnology is headquartered in Hefei, China.

  • What industry is Afana Biotechnology in?

    Afana Biotechnology’s primary industry is Drug Discovery.

  • Is Afana Biotechnology a private or public company?

    Afana Biotechnology is a Private company.

  • What is Afana Biotechnology’s current revenue?

    The current revenue for Afana Biotechnology is .

  • Who are Afana Biotechnology’s investors?

    Shenzhen Guozhong Venture Capital Management, Anhui Lianyuan Venture Capital, Hefei Innovation Technology Venture Capital, USTC Silicon Valley, and Anhui Capital are 5 of 13 investors who have invested in Afana Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process